TOMI Environmental Solutions announced preliminary Q3 2026 revenue of $2.5 million, a 27% increase year-over-year, driven by growth in equipment, services, and automated projects. The company’s order backlog remains strong at $2.5 million, with $1.7 million already booked for Q4, supporting a total recognized sales and backlog of $9 million for 2026 so far. TOMI expects continued profitability and aims to reach $12 million in revenue for the full year, leveraging its leading disinfection technology and expanding market demand. Full Q3 financial results will be reported in the upcoming quarterly filing.
TOMI Environmental Solutions' preliminary Q3 2026 revenue report provides context for industrial sector performance. For readers following Industrials, here is Pluang's market snapshot as of Oct 08, 2026 18:32 WIB: Of 93 priced Industrials-sector US stocks tradable on Pluang, 21 rose and 69 fell today. Notable movers include Ryanair Holdings plc (RYAAY) at USD 54.34 with a 1-day change of -2.96% and a typical hold time on Pluang of 71 days; Planet Labs (PL) at USD 17.25 with a 1-day change of -2.82%, typical hold time 3 days, and Pluang order activity 94% Sell / 6% Buy; and Byrna Technologies Inc (BYRN) at USD 4.16 with a 1-day change of +2.72%, typical hold time 16 days, and Pluang order activity 11% Sell / 89% Buy.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
